(R)-2-((4-(3-Aminopiperidin-1-yl)-3-(but-2-yn-1-yl)-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)methyl)benzoic acid

ID: ALA4538597

Chembl Id: CHEMBL4538597

PubChem CID: 155549522

Max Phase: Preclinical

Molecular Formula: C21H24N4O4

Molecular Weight: 396.45

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC#CCn1c(N2CCC[C@@H](N)C2)cc(=O)n(Cc2ccccc2C(=O)O)c1=O

Standard InChI:  InChI=1S/C21H24N4O4/c1-2-3-11-24-18(23-10-6-8-16(22)14-23)12-19(26)25(21(24)29)13-15-7-4-5-9-17(15)20(27)28/h4-5,7,9,12,16H,6,8,10-11,13-14,22H2,1H3,(H,27,28)/t16-/m1/s1

Standard InChI Key:  KHLOLWFTVYQPED-MRXNPFEDSA-N

Alternative Forms

  1. Parent:

    ALA4538597

    ---

Associated Targets(Human)

DPP4 Tclin Dipeptidyl peptidase IV (7109 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DPP8 Tchem Dipeptidyl peptidase VIII (2139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DPP9 Tchem Dipeptidyl peptidase IX (1624 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 396.45Molecular Weight (Monoisotopic): 396.1798AlogP: 0.71#Rotatable Bonds: 5
Polar Surface Area: 110.56Molecular Species: ZWITTERIONHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.80CX Basic pKa: 9.47CX LogP: -0.24CX LogD: -0.24
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.72Np Likeness Score: -0.66

References

1. Huang J, Deng X, Zhou S, Wang N, Qin Y, Meng L, Li G, Xiong Y, Fan Y, Guo L, Lan D, Xing J, Jiang W, Li Q..  (2019)  Identification of novel uracil derivatives incorporating benzoic acid moieties as highly potent Dipeptidyl Peptidase-IV inhibitors.,  27  (4): [PMID:30642693] [10.1016/j.bmc.2019.01.001]
2. Kumar S, Mittal A, Mittal A..  (2021)  A review upon medicinal perspective and designing rationale of DPP-4 inhibitors.,  46  [PMID:34428715] [10.1016/j.bmc.2021.116354]

Source